Document Detail

Evaluation of imprecision for cardiac troponin assays at low-range concentrations.
MedLine Citation:
PMID:  14656904     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (MI) has recommended that an increased cardiac troponin should be defined as a measurement above the 99th percentile value of the reference group. A total imprecision (CV) at the decision limit of </=10% is recommended. However, peer-reviewed data on assay imprecision are lacking. The purpose of this study was to construct the clinically relevant imprecision profiles for each of the commercially available cardiac troponin assays. Pools of human sera containing cardiac troponin concentrations around the MI decision limit were assessed to identify the lowest concentration associated with a 10% CV. METHODS: Eight serum pools targeting different concentrations of cardiac troponin (I and T) were prepared and stored at -70 degrees C until usage. The cardiac troponin measurement protocol consisted of two replicates per specimen per run, and one run per day for 20 days, using two reagent lots and three calibrations. Manufacturers of each cardiac troponin assay directly performed the measurements. Data analysis for each assay was centralized and performed according to the NCCLS EP5-A guideline. RESULTS: The lowest concentrations (microg/L) providing a 10% CV were as follows: AxSYM, 1.22; ACS:180, 0.37; Centaur, 0.33; Immuno 1, 0.34; Access, 0.06; Vidas, 0.36; Liaison, 0.065; Dimension, 0.26; Opus, 0.90; Stratus CS, 0.10; Immulite, 0.32; Vitros ECi, 0.44; Elecsys, 0.04; AIA 21, 0.09. CONCLUSION: No cardiac troponin assay was able to achieve the 10% CV recommendation at the 99th percentile reference limit defined by the manufacturer.
Mauro Panteghini; Franca Pagani; Kiang-Teck J Yeo; Fred S Apple; Robert H Christenson; Francesco Dati; Johannes Mair; Jan Ravkilde; Alan H B Wu;
Related Documents :
21345844 - Growth-differentiation factor 15 as predictor of mortality in acute reperfused st-eleva...
21440414 - Echocardiographic predictors of left atrial appendage thrombus formation.
21477224 - Localized reentry as a novel type of the proarrhythmic effects of linear ablation in th...
6766824 - Optimal diagnosis in acute myocardial infarction. a cost-effectiveness study.
14677154 - Evaluation of myocardial perfusion and left ventricular function six months after percu...
7815464 - Mechanical abnormalities in the rat ischemic heart failure model which lie downstream t...
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't     Date:  2003-12-04
Journal Detail:
Title:  Clinical chemistry     Volume:  50     ISSN:  0009-9147     ISO Abbreviation:  Clin. Chem.     Publication Date:  2004 Feb 
Date Detail:
Created Date:  2004-01-30     Completed Date:  2004-02-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421549     Medline TA:  Clin Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  327-32     Citation Subset:  IM    
Laboratorio Analisi Chimico Cliniche 1, Azienda Ospedaliera 'Spedali Civili', 25125 Brescia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clinical Chemistry Tests / methods,  standards,  statistics & numerical data*
Myocardial Infarction / diagnosis
Reference Values
Sensitivity and Specificity
Troponin I / blood*
Troponin T / blood*
Reg. No./Substance:
0/Troponin I; 0/Troponin T

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Quantification of serum and urinary S-adenosylmethionine and S-adenosylhomocysteine by stable-isotop...
Next Document:  Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid ...